|
[1] CHEN W,ZHENG R,BAADE PD,et al. Cancer statistics in China,2015[J]. CA Cancer J Clin,2016,66(2):115-132.
|
|
[2] MING L,THORGEIRSSON SS,GAIL MH,et al. Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong,China[J]. Hepatology,2002,36(5):1214-1220.
|
|
[3] EL-SERAG HB. Epidemiology of hepatocellular carcinoma in USA[J]. Hepatol Res,2007,37(Suppl 2):88-94.
|
|
[4] PARKIN DM. The global health burden of infection-associated cancers in the year 2002[J]. Int J Cancer,2006,118(12):3030-3044.
|
|
[5] CHANG W. Non-coding RNAs and Berberine:A new mechanism of its anti-diabetic activities[J]. Eur J Pharmacol,2017,795:8-12.
|
|
[6] LI HM,DANG WT,YANG XH. Advances in anti-inflammatory mechanism of berberine[J]. China Med Herald,2017,14(33):31-34.(in Chinese)李红枚，党万太，杨小红．小檗碱抗炎机制的研究进展[J]．中国医药导报，2017,14(33):31-34.
|
|
[7] KUMAR A,EKAVALI,CHOPRA K,et al. Current knowledge and pharmacological profile of berberine:An update[J]. Eur J Pharmacol,2015,761:288-297.
|
|
[8] SUN SP. Effect of Berberine on the serum levels of IL-10,IL-6and CRP in patients with type 2 diabetes mellitus[J]. J Changchun Univ Chin Med,2017,33(3):431-433.(in Chinese)孙水平．黄连素对2型糖尿病患者血清IL-10、IL-6及CRP水平的影响[J]．长春中医药大学学报，2017,33(3):431-433.
|
|
[9] GUAMN ORTIZ LM,TILLHON M,PARKS M,et al. Multiple effects of berberine derivatives on colon cancer cells[J]. Biomed Res Int,2014,2014:924585.
|
|
[10] PIYANUCH R,SUKHTHANKAR M,WANDEE G,et al. Berberine,a natural isoquinoline alkaloid,induces NAG-1 and ATF3expression in human colorectal cancer cells[J]. Cancer Lett,2007,258(2):230-240.
|
|
[11] GOTO H,KARIYA R,SHIMAMOTO M,et al. Antitumor effect of berberine against primary effusion lymphoma via inhibition of NF-κB pathway[J]. Cancer Sci,2012,103(4):775-781.
|
|
[12] PATIL JB,KIM J,JAYAPRAKASHA GK. Berberine induces apoptosis in breast cancer cel s(MCF-7)through mitochondrial-dependent pathway[J]. Eur J Pharmacol,2010,645(1-3):70-78.
|
|
[13] KIM JB,YU JH,KO E,et al. The alkaloid Berberine inhibits the growth of Anoikis-resistant MCF-7 and MDA-MB-231breast cancer cell lines by inducing cell cycle arrest[J]. Phytomedicine,2010,17(6):436-440.
|
|
[14] SHUKLA S,SHARMA A,PANDEY VK,et al. Concurrent acetylation of Fox O1/3a and p53 due to sirtuins inhibition elicit Bim/PUMA mediated mitochondrial dysfunction and apoptosis in berberine-treated HepG2 cells[J]. Toxicol Appl Pharmacol,2016,291:70-83.
|
|
[15] HWANG JM,KUO HC,TSENG TH,et al. Berberine induces apoptosis through a mitochondria/caspases pathway in human hepatoma cells[J]. Arch Toxicol,2006,80(2):62-73.
|
|
[16] LI F,DONG X,LIN P,et al. Regulation of Akt/Fox O3a/Skp2axis is critically involved in berberine-induced cell cycle arrest in hepatocellular carcinoma cells[J]. Int J Mol Sci,2018,19(2):327-339.
|
|
[17] KE R,VISHNOI K,VISWAKARMA N,et al. Involvement of AMPactivated protein kinase and death receptor 5 in TRAIL-Berberine-induced apoptosis of cancer cells[J]. Sci Rep,2018,8(1):5521.
|
|
[18] LEE YS,KIM WS,KIM KH,et al. Berberine,a natural plant product,activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states[J]. Diabetes,2006,55(8):2256-2264.
|
|
[19] LI J,LI O,KAN M,et al. Berberine induces apoptosis by suppressing the arachidonic acid metabolic pathway in hepatocellular carcinoma[J]. Mol Med Rep,2015,12(3):4572-4577.
|
|
[20] LA X,ZHANG L,LI Z,et al. Berberine-induced autophagic cell death by elevating GRP78 levels in cancer cells[J]. Oncotarget,2017,8(13):20909-20924.
|
|
[21] CHU Q,JIANG Y,ZHANG W,et al. Pyroptosis is involved in the pathogenesis of human hepatocellular carcinoma[J]. Oncotarget,2016,7(51):84658-84665.
|
|
[22] WANG XB,WANG N,LI HL,et al. Up-regulation of PAI-1and down-regulation of u PA are involved in suppression of invasiveness and motility of hepatocellular carcinoma cells by a natural compound berberine[J]. Int J Mol Sci,2016,17(4):577.
|
|
[23] TSANG CM,CHEUNG KC,CHEUNG YC,et al. Berberine suppresses Id-1 expression and inhibits the growth and development of lung metastases in hepatocellular carcinoma[J]. Biochim Biophys Acta,2015,1852(3):541-551.
|
|
[24] DAI B,MA Y,YANG T,et al. Synergistic effect of berberine and HMQ1611 impairs cell proliferation and migration by regulating Wnt signaling pathway in hepatocellular carcinoma[J].Phytother Res,2019,33(3):745-755.
|
|
[25] HUANG YZ,WANG KY,GU CX,et al. Berberine,a natural plant alkaloid, synergistically sensitizes human liver cancer cells to sorafenib[J]. Oncol Rep,2018,40(3):1525-1532.
|
|
[26] GUO N,YAN A,GAO X,et al. Berberine sensitizes rapamycin-mediated human hepatoma cell death in vitro[J]. Mol Med Rep,2014,10(6):3132-3138.
|
|
[27] CHUANG TY,WU HL,MIN J,et al. Berberine regulates the protein expression of multiple tumorigenesis-related genes in hepatocellular carcinoma cell lines[J]. Cancer Cell Int,2017,17(1):59-66.
|
|
[28] CHEN J,WU FX,LUO HL,et al. Berberine upregulates miR-22-3p to suppress hepatocellular carcinoma cell proliferation by targeting Sp1[J]. Am J Transl Res,2016,8(11):4932-4941.
|
|
[29] LUO Y,TIAN G,ZHUANG Z,et al. Berberine prevents nonalcoholic steatohepatitis-derived hepatocellular carcinoma by inhibiting inflammation and angiogenesis in mice[J]. Am J Transl Res,2019,11(5):2668-2682.
|
|
[30] WANG N,WANG XB,TAN HY,et al. Berberine suppresses Cyclin D1 expression through proteasomal degradation in human hepatoma cells[J]. Int J Mol Sci,2016,17(11):e1899.
|
|
[31] CHANDIRASEGARAN G,ELANCHEZHIYAN C,GHOSH K. Effects of Berberine chloride on the liver of streptozotocin-induced diabetes in albino Wistar rats[J]. Biomed Pharmacother,2018,99:227-236.
|
|
[32] PAECH F,MINGARD C,GRüNIG D,et al. Mechanisms of mitochondrial toxicity of the kinase inhibitors ponatinib,regorafenib and sorafenib in human hepatic HepG2 cells[J]. Toxicology,2018,395:34-44.
|
|
[33] JIANG Y,HU JL,MA JL,et al. Antioxidant effect of berberine in a rat model of nonalcoholic steatohepatitis[J]. J Clin Hepatol,2018,34(6):1273-1276.(in Chinese)蒋煜，胡居龙，马佳丽，等．非酒精性脂肪性肝炎大鼠模型中小檗碱抗氧化效应的观察[J]．临床肝胆病杂志，2018,34(6):1273-1276.
|
|
[34] LI XW,WANG JJ,LIANG ST,et al. Mechanism of liver cancer cell apoptosis induced by berberine:The roles of ROS and caspase pathway[J]. Guangdong Med J,2017,38(11):1663-1667.(in Chinese)李晓武，王俊江，梁顺添，等．小檗碱通过ROS及caspase通路对肝癌HepG2细胞凋亡的作用[J]．广东医学，2017,38(11):1663-1667.
|
|
[35] LEE MS,HSU CC,WAHLQVIST ML,et al. Type 2 diabetes increases and metformin reduces total,colorectal,liver and pancreatic cancer incidences in Taiwanese:A representative population prospective cohort study of 800,000 individuals[J]. BMC Cancer,2011,11:20.
|
|
[36] ELKRIEF L,CHOUINARD P,BENDERSKY N,et al. Diabetes mellitus is an independent prognostic factor for major liver-related outcomes in patients with cirrhosis and chronic hepatitis C[J]. Hepatology,2014,60(3):823-831.
|
|
[37] TEOH NC,FAN JG. Diabetes mellitus and prognosis after curative therapy for hepatocellular carcinoma:Alas,still grave for those who are hyperglycemic[J]. J Gastroenterol Hepatol,2008,23(11):1633-1634.
|
|
[38] LI X,XU H,GAO Y,et al. Diabetes mellitus increases the risk of hepatocellular carcinoma in treatment-nave chronic hepatitis C patients in China[J]. Medicine(Baltimore),2017,96(13):e6508.
|
|
[39] ZHANG H,WEI J,XUE R,et al. Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression[J]. Metabolism,2010,59(2):285-292.
|
|
[40] LAN J,ZHAO Y,DONG F,et al. Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus,hyperlipemia and hypertension[J]. J Ethnopharmacol,2015,161:69-81.
|
|
[41] KONG WJ,ZHANG H,SONG DQ,et al. Berberine reduces insulin resistance through protein kinase C-dependent upregulation of insulin receptor expression[J]. Metabolism,2009,58(1):109-119.
|
|
[42] XIA X,YAN J,SHEN Y,et al. Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis[J]. PLo S One,2011,6(2):e16556.
|
|
[43] LI M,ZHANG M,ZHANG ZL,et al. Induction of apoptosis by berberine in hepatocellular carcinoma HepG2 cells via downregulation of NF-κB[J]. Oncol Res,2017,25(2):233-239.
|
DownLoad: